<SEC-DOCUMENT>0000899243-22-024031-index.html : 20220624
<SEC-HEADER>0000899243-22-024031.hdr.sgml : 20220624
<ACCEPTANCE-DATETIME>20220624164845
ACCESSION NUMBER:		0000899243-22-024031
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220324
FILED AS OF DATE:		20220624
DATE AS OF CHANGE:		20220624

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Global Health Technology Fund, L.P.
		CENTRAL INDEX KEY:			0001783165
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040720

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Global Health Technology Fund DE, L.P.
		CENTRAL INDEX KEY:			0001799812
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040719

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Capital GP, L.P.
		CENTRAL INDEX KEY:			0001935100
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040718

	BUSINESS ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Capital Management, LLC
		CENTRAL INDEX KEY:			0001935084
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040717

	BUSINESS ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN2 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001880438
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820606654
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
		BUSINESS PHONE:		(650) 331-9090

	MAIL ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc3a.xml
<DESCRIPTION>FORM 3/A SUBMISSION
<TEXT>
Document 1 - file: doc3a.html

Document 1 - RAW XML: doc3a.xml

</DOCUMENT>
</SEC-DOCUMENT>